申请人:Burgdorf Lars
公开号:US20130225569A1
公开(公告)日:2013-08-29
Compounds of the formula I
in which R
1
and R
2
have the meanings indicated in Claim
1,
are inhibitors of Syk, and can be employed, inter alia, for the treatment of rheumatoid arthritis and/or systemic lupus
式I的化合物中,其中R1和R2具有权利要求1中所示的含义,是Syk的抑制剂,可以用于治疗类风湿性关节炎和/或系统性红斑狼疮等疾病。